Checking clinical trials website, I only see two other interventional drug trials listed at Albert Einstein for acute moderate or critical covid.

Rivaroxaban for treatment and Apixaban for prophylaxis of thrombotic events.

I searched in a number of ways, but there may be other trials not captured.

Nonetheless, it appears that Cytodyn is well placed
to enroll CD16 and 17 quickly though Albert Einstein, capitalizing on the current wave of infections.